Imbruvica 140 mg (Ibrutinib)
Active Ingredient | Ibrutinib |
---|---|
Dosage Form | Capsule |
Available Strength | 140mg |
Manufacturer: | Johnson & Johnson |
Packaging | 90 capsules in 1 bottle |
Therapeutic use | Mantle-cell lymphoma, Blood cancer (Chronic lymphocytic leukemia) |
Pack Insert/Leaflet | Yes |
Production Capacity | 1 Million Bottle's/Month |
Reviews
There are no reviews yet.